Nvelop Therapeutics has raised $75M in total funding. Latest round: Seed. Backed by Newpath Partners, Atlas Venture, F-Prime Capital.
Nvelop Therapeutics funding overview
Nvelop Therapeutics has raised $75M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Seed announced in December 2024. The round record for Nvelop Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Newpath Partners, Atlas Venture, F-Prime Capital, 5AM Ventures, GV, ARCH Venture Partners. 6 distinct backers are named across the disclosed rounds.
Frequently asked about Nvelop Therapeutics funding
How much has Nvelop Therapeutics raised?
Nvelop Therapeutics has raised $75M in total disclosed funding across the rounds on record.
Who has invested in Nvelop Therapeutics?
Newpath Partners, Atlas Venture, F-Prime Capital, 5AM Ventures, GV, ARCH Venture Partners are named among the investors backing Nvelop Therapeutics.
What was the latest Nvelop Therapeutics funding round?
The most recent disclosed round is a Seed, announced in December 2024.
Where is Nvelop Therapeutics based?
No headquarters location is disclosed for Nvelop Therapeutics.
When did Nvelop Therapeutics last raise?
The last disclosed Nvelop Therapeutics round closed in December 2024 at Seed.
Nvelop Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies below to benchmark round size and investor mix.
